PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,515,000 | +7.8% | 312,800 | -0.0% | 0.03% | 0.0% |
| Q1 2018 | $2,334,000 | +16.1% | 312,900 | -7.4% | 0.03% | +12.5% |
| Q4 2017 | $2,010,000 | -38.5% | 337,800 | -24.0% | 0.02% | -40.0% |
| Q3 2017 | $3,269,000 | +7.9% | 444,200 | -0.5% | 0.04% | 0.0% |
| Q2 2017 | $3,030,000 | -28.4% | 446,300 | -0.4% | 0.04% | -31.0% |
| Q1 2017 | $4,229,000 | +9.2% | 448,000 | 0.0% | 0.06% | 0.0% |
| Q4 2016 | $3,871,000 | +36.5% | 448,000 | 0.0% | 0.06% | +23.4% |
| Q3 2016 | $2,836,000 | +45.8% | 448,000 | -2.8% | 0.05% | +42.4% |
| Q2 2016 | $1,945,000 | -3.2% | 460,900 | +0.0% | 0.03% | -15.4% |
| Q1 2016 | $2,009,000 | -46.1% | 460,800 | -24.2% | 0.04% | -51.2% |
| Q4 2015 | $3,726,000 | +12.6% | 607,900 | +5.0% | 0.08% | -7.0% |
| Q3 2015 | $3,310,000 | -23.3% | 578,700 | +0.1% | 0.09% | -29.5% |
| Q2 2015 | $4,314,000 | +27.4% | 578,300 | +2.1% | 0.12% | +13.0% |
| Q1 2015 | $3,386,000 | -21.1% | 566,200 | -0.3% | 0.11% | -30.3% |
| Q4 2014 | $4,294,000 | +47.9% | 568,000 | +1.5% | 0.16% | +24.0% |
| Q3 2014 | $2,904,000 | +20.4% | 559,500 | 0.0% | 0.12% | +22.5% |
| Q2 2014 | $2,411,000 | +16.5% | 559,500 | +10.6% | 0.10% | +2.0% |
| Q1 2014 | $2,070,000 | – | 506,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|